Your browser doesn't support javascript.
loading
Risankizumab-induced paradoxical pustular psoriasis.
McFeely, O; Pender, E; Victory, L; Almutlaq, H; Storan, E.
Afiliação
  • McFeely O; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland.
  • Pender E; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland.
  • Victory L; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland.
  • Almutlaq H; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland.
  • Storan E; Department of Dermatology, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Clin Exp Dermatol ; 47(3): 616-617, 2022 Mar.
Article em En | MEDLINE | ID: mdl-34748673
ABSTRACT
A 45-year-old white woman established on risankizumab self-presented to our service with pustular psoriasis affecting 60% of her body surface area. No history of pustular psoriasis was described in the 22 years that she had been diagnosed with psoriasis. This, to our knowledge, is the first case of paradoxical pustular psoriasis associated with risankizumab.
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Fármacos Dermatológicos / Subunidade p19 da Interleucina-23 / Anticorpos Monoclonais Limite: Female / Humans / Middle aged Idioma: En Revista: Clin Exp Dermatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irlanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Fármacos Dermatológicos / Subunidade p19 da Interleucina-23 / Anticorpos Monoclonais Limite: Female / Humans / Middle aged Idioma: En Revista: Clin Exp Dermatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irlanda